On the public citation graph

Plasma levels of neuropeptides in Alzheimer's disease

https://doi.org/10.1080/09513590500519385
0 signed · 83 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.1975.00490510088009openalex-snapshot
Cerebral Blood Flow in Dementia
inferredcites →https://doi.org/10.1001/archneur.1988.00520270043019openalex-snapshot
Cerebrospinal Fluid Somatostatin and Neuropeptide Y
inferredcites →https://doi.org/10.1001/jama.1963.03060120024016openalex-snapshot
Studies of Illness in the Aged
inferredcites →https://doi.org/10.1001/jama.283.12.1615openalex-snapshot
The Origins of Alzheimer Disease
inferredcites →https://doi.org/10.1002/jnr.10611openalex-snapshot
Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
inferredcites →https://doi.org/10.1016/0006-3223(94)00239-yopenalex-snapshot
Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia
inferredcites →https://doi.org/10.1016/0014-5793(94)01430-9openalex-snapshot
Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences
inferredcites →https://doi.org/10.1016/0022-3956(75)90026-6openalex-snapshot
“Mini-mental state”
inferredcites →https://doi.org/10.1016/0304-3940(93)90686-fopenalex-snapshot
Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex
inferredcites →https://doi.org/10.1016/0304-3940(95)11973-zopenalex-snapshot
Plasma neuropeptide Y is reduced in patients with Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.beem.2004.02.004openalex-snapshot
Endocrinology of anorexia of ageing
inferredcites →https://doi.org/10.1016/s0010-9452(75)80026-8openalex-snapshot
Verbal and Non-Verbal Short-Term Memory Impairment Following Hemispheric Damage
inferredcites →https://doi.org/10.1016/s0196-9781(96)00168-4openalex-snapshot
Novel Neuropeptide Y Processing in Human Cerebrospinal Fluid From Depressed Patients
inferredcites →https://doi.org/10.1016/s0736-5748(98)00082-3openalex-snapshot
Effects of amyloid precursor protein derivatives andoxidative stress on basal forebrain cholinergic systems inALZHEIMERS disease
inferredcites →https://doi.org/10.1016/s0899-9007(01)00574-3openalex-snapshot
Anorexia, sarcopenia, and aging
inferredcites →https://doi.org/10.1038/35038090openalex-snapshot
Ghrelin induces adiposity in rodents
inferredcites →https://doi.org/10.1038/45016openalex-snapshot
NASA facing awkward questions as hopes for Mars lander fade
inferredcites →https://doi.org/10.1038/45230openalex-snapshot
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
inferredcites →https://doi.org/10.1046/j.1471-4159.1995.64010299.xopenalex-snapshot
Structural Characterization by Affinity Cross‐Linking of Glucagon‐Like Peptide‐1(7–36)Amide Receptor in Rat Brain
inferredcites →https://doi.org/10.1046/j.1471-4159.1995.65041740.xopenalex-snapshot
Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca 2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons
inferredcites →https://doi.org/10.1055/s-2004-835375openalex-snapshot
The Role of the Somatotropic System in Cognition and Other Cerebral Functions
inferredcites →https://doi.org/10.1056/nejm199205143262003openalex-snapshot
Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus
inferredcites →https://doi.org/10.1079/bjn20041142openalex-snapshot
Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects
inferredcites →https://doi.org/10.1093/ajcn/66.4.760openalex-snapshot
Anorexia of aging: physiologic and pathologic
inferredcites →https://doi.org/10.1093/ajcn/71.2.637sopenalex-snapshot
Weight loss in Alzheimer disease
inferredcites →https://doi.org/10.1093/geront/9.3_part_1.179openalex-snapshot
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
inferredcites →https://doi.org/10.1111/j.1460-9568.1995.tb00650.xopenalex-snapshot
Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites
inferredcites →https://doi.org/10.1111/j.1749-6632.1995.tb44683.xopenalex-snapshot
Neuropeptide Y
inferredcites →https://doi.org/10.1111/j.2044-8260.1967.tb00530.xopenalex-snapshot
Development of a Rating Scale for Primary Depressive Illness
inferredcites →https://doi.org/10.1124/jpet.102.037481openalex-snapshot
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
inferredcites →https://doi.org/10.1136/jnnp.57.12.1510openalex-snapshot
A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment.
inferredcites →https://doi.org/10.1152/physrev.1997.77.4.1081openalex-snapshot
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
inferredcites →https://doi.org/10.1159/000107318openalex-snapshot
Neuropeptides in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Dementia with Frontotemporal Lobe Degeneration
inferredcites →https://doi.org/10.1159/000117347openalex-snapshot
Cerebrospinal Fluid Neuropeptide Y in Alzheimer’s Disease
inferredcites →https://doi.org/10.1176/ajp.139.9.1136openalex-snapshot
The Global Deterioration Scale for assessment of primary degenerative dementia
inferredcites →https://doi.org/10.1176/appi.psychotherapy.1959.13.4.989openalex-snapshot
L’examen Clinique en Psychologie
inferredcites →https://doi.org/10.1210/en.134.5.2156openalex-snapshot
Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse
inferredcites →https://doi.org/10.1210/en.137.11.5159openalex-snapshot
Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus
inferredcites →https://doi.org/10.1210/en.141.12.4600openalex-snapshot
Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats
inferredcites →https://doi.org/10.1210/en.141.4.1301openalex-snapshot
Characterization of Human and Rat Glucagon-Like Peptide-1 Receptors in the Neurointermediate Lobe: Lack of Coupling to Either Stimulation or Inhibition of Adenylyl Cyclase
inferredcites →https://doi.org/10.1300/j018v01n01_06openalex-snapshot
Screening Tests for Geriatric Depression
inferredcites →https://doi.org/10.1301/nr.2003.may.157-167openalex-snapshot
Sarcopenia and Aging
inferredcites →https://doi.org/10.1677/joe.0.175r001openalex-snapshot
Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients
inferredcites →https://doi.org/10.2174/1389203033380296openalex-snapshot
Hormonal Control of the Neuropeptide Y System
inferredcites →https://doi.org/10.2174/1389450043345245openalex-snapshot
A New Alzheimers Disease Interventive Strategy: GLP-1

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3924201openalex-extracted
Combined Metabolic Activators Improves Cognitive Functions in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/alz.13864openalex-snapshot
Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
inferred← citeshttps://doi.org/10.1002/oby.20066openalex-snapshot
Possible risk factors for increased suicide following bariatric surgery
inferred← citeshttps://doi.org/10.1007/s00005-014-0287-9openalex-snapshot
Ghrelin Gene Products in Acute and Chronic Inflammation
inferred← citeshttps://doi.org/10.1007/s12035-015-9227-xopenalex-snapshot
Effects of Ghrelin on the Proteolytic Pathways of Alzheimer’s Disease Neuronal Cells
inferred← citeshttps://doi.org/10.1007/s12035-016-9729-1openalex-snapshot
Ghrelin and Neurodegenerative Disorders—a Review
inferred← citeshttps://doi.org/10.1007/s12603-012-0058-4openalex-snapshot
Ghrelin and leptin secretion in patients with moderate Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.conb.2022.102655openalex-snapshot
Ghrelin system in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.encep.2017.10.012openalex-snapshot
The effects of ghrelin on sleep, appetite, and memory, and its possible role in depression: A review of the literature
inferred← citeshttps://doi.org/10.1016/j.nbd.2014.08.026openalex-snapshot
Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.nbd.2016.07.022openalex-snapshot
Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.npep.2015.09.008openalex-snapshot
Neuropeptide Y: A stressful review
inferred← citeshttps://doi.org/10.1016/j.npep.2025.102583openalex-snapshot
Neuropeptide Y at the crossroads of neurodegeneration: Mechanistic insights and emerging therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.peptides.2011.09.019openalex-snapshot
Role of ghrelin system in neuroprotection and cognitive functions: Implications in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.phrs.2012.06.006openalex-snapshot
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues
inferred← citeshttps://doi.org/10.1016/j.phrs.2018.01.018openalex-snapshot
Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.psyneuen.2014.11.013openalex-snapshot
Ghrelin in psychiatric disorders – A review
inferred← citeshttps://doi.org/10.1016/j.yfrne.2013.08.001openalex-snapshot
Estrogen: A master regulator of bioenergetic systems in the brain and body
inferred← citeshttps://doi.org/10.1080/02699052.2019.1587000openalex-snapshot
GLP-1’s role in neuroprotection: a systematic review
inferred← citeshttps://doi.org/10.1515/revneuro-2025-0034openalex-snapshot
Antimicrobial peptides and proteins in Alzheimer’s and Parkinson’s diseases: implications for biomarker exploration
inferred← citeshttps://doi.org/10.1530/joe-13-0391openalex-snapshot
Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight
inferred← citeshttps://doi.org/10.15406/emij.2017.04.00091openalex-snapshot
Diabetes, Neurodegenerative Diseases, GLP-1 & Surgery: Evidence Calls for Exploration
inferred← citeshttps://doi.org/10.15406/emij.4.4openalex-snapshot
inferred← citeshttps://doi.org/10.21203/rs.3.rs-490560/v1openalex-snapshot
Serum Ghrelin in Mild Cognitive Impairment and Alzheimer's Disease A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.2174/13816128113199990411openalex-snapshot
Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
inferred← citeshttps://doi.org/10.2174/1567205016666190503152555openalex-snapshot
Neuropeptides in Alzheimer’s Disease: An Update
inferred← citeshttps://doi.org/10.2174/156720512799015037openalex-snapshot
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
inferred← citeshttps://doi.org/10.23889/suthesis.58915openalex-snapshot
Characterisation of the ghrelinergic system in human models of neurodegenerative diseases
inferred← citeshttps://doi.org/10.3233/jad-170721openalex-snapshot
Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment
inferred← citeshttps://doi.org/10.3233/jad-2010-100873openalex-snapshot
Expression of the Ghrelin and Neurotensin Systems is Altered in the Temporal Lobe of Alzheimer's Disease Patients
inferred← citeshttps://doi.org/10.3389/fnagi.2014.00234openalex-snapshot
Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer’s disease?
inferred← citeshttps://doi.org/10.3389/fnins.2020.614828openalex-snapshot
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
inferred← citeshttps://doi.org/10.3390/brainsci3010344openalex-snapshot
The Role of Ghrelin in Neuroprotection after Ischemic Brain Injury
inferred← citeshttps://doi.org/10.3390/ijms18040798openalex-snapshot
Therapeutic Potential of Targeting the Ghrelin Pathway
inferred← citeshttps://doi.org/10.3390/ijms22147629openalex-snapshot
Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)
inferred← citeshttps://doi.org/10.3390/neurolint16060100openalex-snapshot
The Role of Neuropeptide Y in the Pathogenesis of Alzheimer’s Disease: Diagnostic Significance and Neuroprotective Functions
inferred← citeshttps://doi.org/10.5897/ajbr.9000188openalex-snapshot
Plasma concentration of acylated ghrelin in patients with Alzheimers disease
inferred← citeshttps://doi.org/10.70675/d97d79f9z943fz4874z9d8bzd6c690108632openalex-snapshot
Différences mâles/femelles dans les effets de l'éthanol sur la plasticité hippocampique chez le rat adolescent : rôle des œstrogènes
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.